https://www.laboratoire-cicly.fr/publications/non-equilibrium-statistical-physics-transitory-epigenetic-landscapes-and-cell-fate-decision-dynamics/2025-03-25T17:41:27+01:00https://www.laboratoire-cicly.fr/publications/ca-125-elimination-rate-constant-k-kelim-is-a-marker-of-chemosensitivity-in-patients-with-ovarian-cancer-results-from-the-phase-ii-chiva-trial/2025-03-25T17:41:28+01:00https://www.laboratoire-cicly.fr/publications/olaparib-and-durvalumab-in-patients-with-germline-brca-mutated-metastatic-breast-cancer-mediola-an-open-label-multicentre-phase-1-2-basket-study/2025-03-25T17:41:27+01:00https://www.laboratoire-cicly.fr/publications/front-line-maintenance-therapy-in-advanced-ovarian-cancer-current-advances-and-perspectives/2025-03-25T17:41:28+01:00https://www.laboratoire-cicly.fr/publications/reply-to-j-r-lurain-et-al/2025-03-25T17:41:27+01:00https://www.laboratoire-cicly.fr/publications/the-official-french-guidelines-to-protect-patients-with-cancer-against-sars-cov-2-infection/2025-03-25T17:41:27+01:00https://www.laboratoire-cicly.fr/publications/bevacizumab-for-newly-diagnosed-ovarian-cancers-best-candidates-among-high-risk-disease-patients-icon-7/2025-03-25T17:41:28+01:00https://www.laboratoire-cicly.fr/publications/sars-cov-2-covid-19-infection-and-solid-cancers-synthesis-of-recommendations-for-health-professionals/2025-03-25T17:41:27+01:00https://www.laboratoire-cicly.fr/publications/transcriptomic-and-immunohistochemical-approaches-identify-hla-g-as-a-predictive-biomarker-of-gestational-choriocarcinoma-resistance-to-monochemotherapy/2025-03-25T17:41:27+01:00https://www.laboratoire-cicly.fr/publications/avelumab-in-patients-with-gestational-trophoblastic-tumors-with-resistance-to-single-agent-chemotherapy-cohort-a-of-the-trophimmun-phase-ii-trial/2025-03-25T17:41:28+01:00https://www.laboratoire-cicly.fr/publications/comparative-analysis-of-predictive-values-of-the-kinetics-of-11-circulating-mirnas-and-of-ca125-in-ovarian-cancer-during-first-line-treatment-a-gineco-study/2025-03-25T17:41:27+01:00https://www.laboratoire-cicly.fr/publications/the-oncogenic-and-druggable-hpg80-progastrin-is-overexpressed-in-multiple-cancers-and-detected-in-the-blood-of-patients/2025-03-25T17:41:27+01:00https://www.laboratoire-cicly.fr/publications/first-line-bevacizumab-and-eribulin-combination-therapy-for-her2-negative-metastatic-breast-cancer-efficacy-and-safety-in-the-gineco-phase-ii-esmeralda-study/2025-03-25T17:41:27+01:00https://www.laboratoire-cicly.fr/publications/validation-of-an-online-tool-for-early-prediction-of-the-failure-risk-in-gestational-trophoblastic-neoplasia-patients-treated-with-methotrexate/2025-03-25T17:41:28+01:00https://www.laboratoire-cicly.fr/publications/economic-impact-of-clinical-pharmaceutical-activities-in-hospital-wards-a-systematic-review/2025-03-25T17:41:30+01:00https://www.laboratoire-cicly.fr/publications/clinical-and-economic-impact-of-medication-reconciliation-in-cancer-patients-a-systematic-review/2025-03-25T17:41:27+01:00https://www.laboratoire-cicly.fr/publications/cancer-immune-suppression-and-coronavirus-disease-19-covid-19-need-to-manage-drug-safety-french-society-for-oncology-pharmacy-sfpo-guidelines/2025-03-25T17:41:27+01:00https://www.laboratoire-cicly.fr/publications/commercial-anti-cd19-car-t-cell-therapy-for-patients-with-relapsed-refractory-aggressive-b-cell-lymphoma-in-a-european-center/2025-03-25T17:41:27+01:00https://www.laboratoire-cicly.fr/publications/compatibility-of-99mtctc-edda-hynic-toc-and-68ga-ga-dota-toc-in-a-syringe-for-intravenous-administration/2025-03-25T17:41:27+01:00https://www.laboratoire-cicly.fr/publications/drug-cost-savings-in-phase-iii-hematological-oncology-clinical-trials-in-a-university-hospital/2025-03-25T17:41:27+01:00https://www.laboratoire-cicly.fr/publications/encounters-between-medical-and-lay-knowledge-in-therapeutic-patient-education-a-qualitative-study-based-on-an-oral-chemotherapy-program/2025-03-25T17:41:28+01:00https://www.laboratoire-cicly.fr/publications/providing-oncology-pharmacy-services-during-the-coronavirus-pandemic-french-society-for-oncology-pharmacy-societe-francaise-de-pharmacie-oncologique-sfpo-guidelines/2025-03-25T17:41:28+01:00https://www.laboratoire-cicly.fr/publications/immunomodulatory-drugs-in-multiple-myeloma-impact-of-the-scarmet-self-care-and-medication-toxicity-educational-intervention-on-outpatients-knowledge-to-manage-adverse-effects/2025-03-25T17:41:28+01:00https://www.laboratoire-cicly.fr/publications/conditions-for-the-implementation-of-a-patient-education-program-dedicated-to-cancer-patients-treated-by-oral-anticancer-therapy/2025-03-25T17:41:28+01:00https://www.laboratoire-cicly.fr/publications/art-therapy-and-social-function-in-palliative-care-patients-a-mixed-method-pilot-study/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/palliative-care-from-the-perspective-of-cancer-physicians-a-qualitative-semistructured-interviews-study/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/nursing-home-hospital-transfers-in-the-terminally-ill-night-shift-nurses-matter/2025-03-25T17:41:28+01:00https://www.laboratoire-cicly.fr/publications/association-between-immune-related-adverse-events-and-long-term-survival-outcomes-in-patients-treated-with-immune-checkpoint-inhibitors/2025-03-25T17:41:28+01:00https://www.laboratoire-cicly.fr/publications/what-is-the-evidence-for-mirtazapine-in-treating-cancer-related-symptomatology-a-systematic-review/2025-03-25T17:41:28+01:00https://www.laboratoire-cicly.fr/publications/a-realist-review-of-advance-care-planning-for-people-with-multiple-sclerosis-and-their-families/2025-03-25T17:41:28+01:00https://www.laboratoire-cicly.fr/publications/mr-imaging-of-the-perihepatic-space/2025-03-25T17:41:30+01:00https://www.laboratoire-cicly.fr/publications/emergency-surgery-in-acute-diverticulitis-a-systematic-review/2025-03-25T17:41:28+01:00https://www.laboratoire-cicly.fr/publications/rectal-endometriosis-predictive-mri-signs-for-segmental-bowel-resection/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/spectral-photon-counting-ct-imaging-of-colorectal-peritoneal-metastases-initial-experience-in-rats/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/bladder-endometriosis-preoperative-mri-analysis-with-assessment-of-extension-to-ureteral-orifices/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/clinical-and-radiologic-predictors-of-a-pathologic-complete-response-to-neoadjuvant-chemotherapy-nact-in-patients-undergoing-cytoreductive-surgery-for-colorectal-peritoneal-metastases-results-of-a/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/borderline-ovarian-tumors-french-guidelines-from-the-cngof-part-1-epidemiology-biopathology-imaging-and-biomarkers/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/prospective-comparison-of-whole-body-mri-with-diffusion-weighted-and-conventional-imaging-for-the-follow-up-of-neuroendocrine-tumors/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/borderline-ovarian-tumors-french-guidelines-from-the-cngof-part-2-surgical-management-follow-up-hormone-replacement-therapy-fertility-management-and-preservation/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/flagging-performance-of-sysmex-xn-10-haematology-analyser-for-malaria-detection/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/k3-edta-differentially-inhibits-the-growth-of-candida-strains-according-to-their-azole-resistance-status/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/diagnosis-of-ectopic-pancreas-in-small-intestine-with-18f-dopa-pet-ct/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/tertiary-lymphoid-structures-in-epithelioid-malignant-peritoneal-mesothelioma-are-associated-with-neoadjuvant-chemotherapy-but-not-with-prognosis/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/noise-and-the-molecular-processes-underlying-cell-fate-decision-making/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/shaping-the-innate-immune-response-through-post-transcriptional-regulation-of-gene-expression-mediated-by-rna-binding-proteins/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/practical-identifiability-in-the-frame-of-nonlinear-mixed-effects-models-the-example-of-the-in-vitro-erythropoiesis/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/the-quiescent-fraction-of-chronic-myeloid-leukemic-stem-cells-depends-on-bmpr1b-stat3-and-bmp4-niche-signals-to-persist-in-patients-in-remission/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/transcriptomic-characterization-of-postmolar-gestational-choriocarcinoma/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/using-breast-cancer-gene-expression-signatures-in-clinical-practice-unsolved-issues-ongoing-trials-and-future-perspectives/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/the-increasing-prognostic-and-predictive-roles-of-the-tumor-primary-chemosensitivity-assessed-by-ca-125-elimination-rate-constant-k-kelim-in-ovarian-cancer-a-narrative-review/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/the-role-of-the-tumor-primary-chemosensitivity-relative-to-the-success-of-the-medical-surgical-management-in-patients-with-advanced-ovarian-carcinomas/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/prise-en-charge-chirurgicale-du-cancer-epithelial-de-lovaire-premiere-ligne-et-premiere-rechute-surgical-management-of-epithelial-ovarian-cancer-first-line-and-first-relapse/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/methods-and-designs-of-modern-breast-cancer-confirmatory-trials/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/regorafenib-or-tamoxifen-for-platinum-sensitive-recurrent-ovarian-cancer-with-rising-ca125-and-no-evidence-of-clinical-or-recist-progression-a-gineco-randomized-phase-ii-trial-regovar/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/durvalumab-compared-to-maintenance-chemotherapy-in-metastatic-breast-cancer-the-randomized-phase-ii-safir02-breast-immuno-trial/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/appendiceal-tumors-and-pseudomyxoma-peritonei-french-intergroup-clinical-practice-guidelines-for-diagnosis-treatments-and-follow-up-renape-renapath-snfge-ffcd-gercor-unicancer-sfcd-sfed-sfr/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/non-resectable-malignant-peritoneal-mesothelioma-treated-with-pressurized-intraperitoneal-aerosol-chemotherapy-pipac-plus-systemic-chemotherapy-could-lead-to-secondary-complete-cytoreductive-surgery/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/clinical-effectiveness-of-olaparib-monotherapy-in-germline-brca-mutated-her2-negative-metastatic-breast-cancer-in-a-real-world-setting-phase-iiib-lucy-interim-analysis/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/cutting-edge-mtorc1-inhibition-in-metastatic-breast-cancer-patients-negatively-affects-peripheral-nk-cell-maturation-and-number/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/serum-soluble-cd26-dpp4-titer-variation-is-a-potential-prognostic-biomarker-in-cancer-therapy-with-a-humanized-anti-cd26-antibody/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/gestational-trophoblastic-neoplasia-after-human-chorionic-gonadotropin-normalization-in-a-retrospective-cohort-of-7761-patients-in-france/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/associations-between-the-severity-of-medical-and-surgical-complications-and-perception-of-surgeon-empathy-in-esophageal-and-gastric-cancer-patients/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/aso-author-reflections-bi-directional-chemotherapy-using-pipac-could-downstage-nonresectable-malignant-peritoneal-mesothelioma-patients-to-a-complete-resection/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/impact-of-the-first-wave-of-the-covid-19-pandemic-on-the-lyon-university-hospital-cancer-institute-ic-hcl/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/preparations-of-exploration-of-immediate-hypersensitivity-to-antineoplastic-agents-an-oncology-pharmacy-perspective/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/immunosuppression-medication-adherence-after-allogeneic-hematopoietic-stem-cell-transplant-impact-of-a-specialized-clinical-pharmacy-program/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/how-a-patient-personalised-clinical-pharmacy-programme-can-secure-therapeutic-care-in-an-orthogeriatric-care-pathway-5p-project/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/cultural-and-ethical-barriers-to-cancer-treatment-in-nursing-homes-and-educational-strategies-a-scoping-review/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/risk-factors-associated-with-day-30-mortality-in-patients-over-60-years-old-admitted-in-icu-for-severe-covid-19-the-senior-covid-rea-multicentre-survey-protocol/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/feasibility-of-a-prehabilitation-programme-dedicated-to-older-patients-with-cancer-before-complex-medical-surgical-procedures-the-proadapt-pilot-study-protocol/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/knowledge-and-use-of-prognostic-scales-by-oncologists-and-palliative-care-physicians-in-adult-patients-with-advanced-cancer-a-national-survey-oncoprono-study/2025-03-25T17:41:29+01:00https://www.laboratoire-cicly.fr/publications/development-of-clinical-pharmacy-programs-integrated-into-patient-care-pathways-using-adverse-event-risks/2025-03-25T17:41:33+01:00https://www.laboratoire-cicly.fr/publications/prise-en-charge-medicale-de-la-recidive-du-cancer-epithelial-de-lovaire-medical-management-of-recurrent-epithelial-ovarian-cancer/2025-03-25T17:41:30+01:00https://www.laboratoire-cicly.fr/publications/what-is-the-optimal-treatment-for-vulnerable-older-women-with-ovarian-cancer-reply/2025-03-25T17:41:30+01:00https://www.laboratoire-cicly.fr/publications/covid-19-presentation-and-outcomes-among-cancer-patients-a-matched-case-control-study/2025-03-25T17:41:30+01:00https://www.laboratoire-cicly.fr/publications/efficacy-and-safety-of-first-line-single-agent-carboplatin-vs-carboplatin-plus-paclitaxel-for-vulnerable-older-adult-women-with-ovarian-cancer-a-gineco-gcig-randomized-clinical-trial/2025-03-25T17:41:30+01:00https://www.laboratoire-cicly.fr/publications/her2-expression-in-circulating-tumor-cells-is-associated-with-poor-outcomes-in-patients-with-metastatic-castration-resistant-prostate-cancer/2025-03-25T17:41:30+01:00https://www.laboratoire-cicly.fr/publications/improved-androgen-receptor-splice-variant-7-detection-using-a-highly-sensitive-assay-to-predict-resistance-to-abiraterone-or-enzalutamide-in-metastatic-prostate-cancer-patients/2025-03-25T17:41:30+01:00https://www.laboratoire-cicly.fr/publications/tobacco-use-and-related-behaviors-among-staff-and-students-in-a-university-hospital-a-large-cross-sectional-survey/2025-03-25T17:41:30+01:00https://www.laboratoire-cicly.fr/publications/peritoneal-mri-in-patients-undergoing-cytoreductive-surgery-and-hipec-history-clinical-applications-and-implementation/2025-03-25T17:41:30+01:00https://www.laboratoire-cicly.fr/publications/study-of-thoracic-ct-in-covid-19-the-stoic-project/2025-03-25T17:41:30+01:00https://www.laboratoire-cicly.fr/publications/bladder-endometriosis-preoperative-mri-analysis-with-assessment-of-extension-to-ureteral-orifices-2/2025-03-25T17:41:30+01:00https://www.laboratoire-cicly.fr/publications/structured-and-shared-mri-staging-lexicon-and-report-of-rectal-cancer-a-consensus-proposal-by-the-french-radiology-group-grercar-and-surgical-group-greccar-for-rectal-cancer/2025-03-25T17:41:33+01:00https://www.laboratoire-cicly.fr/publications/multicystic-peritoneal-mesothelioma-treated-with-cytoreductive-surgery-followed-or-not-by-hyperthermic-intraperitoneal-chemotherapy-results-from-a-large-multicentric-cohort/2025-03-25T17:41:30+01:00https://www.laboratoire-cicly.fr/publications/uterine-sarcomas-are-there-mri-signs-predictive-of-histopathological-diagnosis-a-50-patient-case-series-with-pathological-correlation/2025-03-25T17:41:30+01:00https://www.laboratoire-cicly.fr/publications/greater-omentum-lesion-score-gols-as-a-predictor-of-residual-disease-in-different-regions-of-the-peritoneal-cavity-in-patients-undergoing-interval-cytoreductive-surgery-for-advanced-ovarian-cancer-a/2025-03-25T17:41:30+01:00https://www.laboratoire-cicly.fr/publications/patterns-of-peritoneal-dissemination-and-response-to-systemic-chemotherapy-in-common-and-rare-peritoneal-tumours-treated-by-cytoreductive-surgery-study-protocol-of-a-prospective-multicentre-observa/2025-03-25T17:41:30+01:00https://www.laboratoire-cicly.fr/publications/progression-free-survival-on-endocrine-therapy-before-or-after-chemotherapy-in-hormone-receptor-positive-her2-negative-metastatic-breast-cancer/2025-03-25T17:41:33+01:00https://www.laboratoire-cicly.fr/publications/investigating-the-impact-of-immune-related-adverse-events-glucocorticoid-use-and-immunotherapy-interruption-on-long-term-survival-outcomes/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/spontaneous-bypass-of-a-haemodialysis-return-vein-stenosis/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/scalloping-of-the-liver-and-spleen-on-preoperative-ct-scan-of-pseudomyxoma-peritonei-patients-impact-on-prediction-of-resectability-grade-morbidity-and-survival/2025-03-25T17:41:33+01:00https://www.laboratoire-cicly.fr/publications/shaping-the-innate-immune-response-through-post-transcriptional-regulation-of-gene-expression-mediated-by-rna-binding-proteins-2/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/identification-of-patients-with-ovarian-cancer-experiencing-the-highest-benefit-from-bevacizumab-in-the-first-line-setting-on-the-basis-of-their-tumor-intrinsic-chemosensitivity-kelim-the-gog-0218/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/genomics-to-select-treatment-for-patients-with-metastatic-breast-cancer/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/trastuzumab-deruxtecan-in-her2-positive-metastatic-breast-cancer-patients-with-brain-metastases-a-destiny-breast01-subgroup-analysis/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/parp-inhibitors-a-major-therapeutic-option-in-endocrine-receptor-positive-breast-cancers/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/cracking-the-homologous-recombination-deficiency-code-how-to-identify-responders-to-parp-inhibitors/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/hpg80-and-cancer-a-new-blood-biomarker-in-development-for-patient-monitoring/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/ca-125-kelim-as-a-potential-complementary-tool-for-predicting-veliparib-benefit-an-exploratory-analysis-from-the-velia-gog-3005-study/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/safety-and-efficacy-of-nivolumab-an-anti-pd1-immunotherapy-in-patients-with-advanced-basal-cell-carcinoma-after-failure-or-intolerance-to-sonic-hedgehog-inhibitors-unicancer-acse-nivolumab-trial/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/optimization-of-g-csf-dosing-schedule-in-patients-treated-with-eribulin-a-modeling-approach/2025-03-25T17:41:33+01:00https://www.laboratoire-cicly.fr/publications/low-probability-of-disease-cure-in-advanced-ovarian-carcinomas-before-the-parp-inhibitor-era/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/hyperthermic-intraperitoneal-chemotherapy-and-cytoreductive-surgery-in-ovarian-cancer-an-umbrella-review-of-meta-analyses/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/avelumab-in-patients-with-gestational-trophoblastic-tumors-with-resistance-to-polychemotherapy-cohort-b-of-the-trophimmun-phase-2-trial/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/safety-and-efficacy-of-the-mtor-inhibitor-vistusertib-combined-with-anastrozole-in-patients-with-hormone-receptor-positive-recurrent-or-metastatic-endometrial-cancer-the-victoria-multicenter-open/2025-03-25T17:41:31+01:00https://www.laboratoire-cicly.fr/publications/effect-of-capmatinib-on-the-pharmacokinetics-of-substrates-of-cyp3a-midazolam-and-cyp1a2-caffeine-in-patients-with-met-dysregulated-solid-tumours/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/paclitaxel-with-or-without-pazopanib-for-ovarian-cancer-relapsing-during-bevacizumab-maintenance-therapy-the-gineco-randomized-phase-ii-tapaz-study/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/a-phase-ii-study-of-navitoclax-abt-263-as-single-agent-in-women-heavily-pretreated-for-recurrent-epithelial-ovarian-cancer-the-monavi-gineco-study/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/predominance-of-brca2-mutation-and-estrogen-receptor-positivity-in-unselected-breast-cancer-with-brca1-or-brca2-mutation/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/assessment-of-patient-reported-outcomes-pros-in-outpatients-taking-oral-anticancer-drugs-included-in-the-real-life-oncoral-program/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/modeled-early-longitudinal-psa-kinetics-prognostic-value-in-rising-psa-prostate-cancer-patients-after-local-therapy-treated-with-adt-docetaxel/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/a-phase-ii-study-evaluating-the-interest-to-combine-ucpvax-a-telomerase-cd4-th1-inducer-cancer-vaccine-and-atezolizumab-for-the-treatment-of-hpv-positive-cancers-volatil-study/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/receiving-handling-storage-thawing-distribution-and-administration-of-car-t-cells-shipped-from-the-manufacturing-facility/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/comparing-different-robots-available-in-the-european-market-for-the-preparation-of-injectable-chemotherapy-and-recommendations-to-users/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/implementation-assessment-of-a-patient-personalized-clinical-pharmacy-programme-5p-project-into-orthogeriatric-care-pathway/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/assessment-of-patient-reported-outcomes-pros-in-outpatients-taking-oral-anticancer-drugs-included-in-the-real-life-oncoral-program-2/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/intravenous-route-for-folate-supplementation-in-a-patient-with-celiac-disease-treated-by-pemetrexed-based-chemotherapy-for-non-small-cell-lung-cancer/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/haematologists-and-palliative-care-a-multicentric-qualitative-study/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/knowledge-and-use-of-prognostic-scales-by-oncologists-and-palliative-care-physicians-in-adult-patients-with-advanced-cancer-a-national-survey-oncoprono-study-2/2025-03-25T17:41:32+01:00https://www.laboratoire-cicly.fr/publications/what-is-the-effectiveness-and-safety-of-mirtazapine-versus-escitalopram-in-alleviating-cancer-associated-poly-symptomatology-the-mir-p-study-a-mixed-method-randomized-controlled-trial-protocol/2025-03-25T17:41:33+01:00https://www.laboratoire-cicly.fr/publications/development-of-artificial-intelligence-powered-apps-and-tools-for-clinical-pharmacy-services-a-systematic-review/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/comparing-different-robots-available-in-the-european-market-for-the-preparation-of-injectable-chemotherapy-and-recommendations-to-users-2/2025-03-25T17:41:33+01:00https://www.laboratoire-cicly.fr/publications/validation-of-the-geriatric-vulnerability-score-in-older-patients-with-ovarian-cancer-an-analysis-from-the-gcig-engot-gineco-ewoc-1-study/2025-03-25T17:41:33+01:00https://www.laboratoire-cicly.fr/publications/deep-pelvic-infiltrating-endometriosis-mri-consensus-lexicon-and-compartment-based-approach-from-the-endovalirm-group/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/advances-in-the-management-of-peritoneal-malignancies/2025-03-25T17:41:33+01:00https://www.laboratoire-cicly.fr/publications/the-bumpy-road-of-peritoneal-metastases-in-ovarian-cancer/2025-03-25T17:41:33+01:00https://www.laboratoire-cicly.fr/publications/pregnancy-in-a-rudimentary-horn-multicenters-mri-features-of-a-rare-condition/2025-03-25T17:41:33+01:00https://www.laboratoire-cicly.fr/publications/accuracy-of-combined-physical-examination-transvaginal-ultrasonography-and-magnetic-resonance-imaging-to-diagnose-deep-endometriosis/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/slowly-absorbable-mesh-versus-standard-care-in-the-management-of-contaminated-midline-incisional-hernia-compact-bio-a-multicentre-randomised-controlled-phase-iii-trial-including-a-health-economic-e/2025-03-25T17:41:33+01:00https://www.laboratoire-cicly.fr/publications/onco-nephrology-physicians-expectations-about-a-new-subspecialty/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/impact-of-liver-metastases-and-number-of-metastatic-sites-on-immune-checkpoint-inhibitors-efficacy-in-patients-with-different-solid-tumors-a-retrospective-study/2025-03-25T17:41:33+01:00https://www.laboratoire-cicly.fr/publications/unexpected-discovery-of-ballistic-metallic-foreign-bodies-on-postmortem-imaging-examinations/2025-03-25T17:41:33+01:00https://www.laboratoire-cicly.fr/publications/temporary-inferior-vena-cava-filters-factors-associated-with-non-removal/2025-03-25T17:41:33+01:00https://www.laboratoire-cicly.fr/publications/safety-and-efficacy-of-emergency-transarterial-embolization-for-mesenteric-bleeding/2025-03-25T17:41:33+01:00https://www.laboratoire-cicly.fr/publications/transarterial-embolization-for-spontaneous-soft-tissue-hematomas-predictive-factors-for-early-death/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/percutaneous-screw-fixation-and-cementoplasty-of-metastatic-sternal-fracture-descriptions-of-2-cases/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/transarterial-embolization-for-active-gastrointestinal-bleeding-predictors-of-early-mortality-and-early-rebleeding/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/gastric-pneumatosis-with-portal-venous-gas-can-be-treated-non-operatively-a-retrospective-multi-institutional-study/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/dorsal-defect-of-the-patella-an-efficient-safe-and-minimally-invasive-treatment-with-percutaneous-sclerotherapy-using-radiopaque-gelified-ethanol/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/combination-of-percutaneous-screw-fixation-and-cementoplasty-for-lytic-bone-metastases-feasibility-safety-and-clinical-outcomes/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/prognostic-factors-of-pelvic-mri-at-the-initial-workflow-in-locally-advanced-rectal-cancer-focus-on-extra-mural-venous-invasion-and-tumour-deposits/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/preventive-tract-embolization-with-gelatin-sponge-slurry-is-safe-and-considerably-reduces-pneumothorax-after-ct-guided-lung-biopsy-with-use-of-large-16-18-coaxial-needles/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/uterine-transarterial-embolization-as-nonsurgical-management-for-uterine-rupture-following-vaginal-delivery-a-report-of-two-cases/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/embryonated-chicken-tumor-xenografts-derived-from-circulating-tumor-cells-as-a-relevant-model-to-study-metastatic-dissemination-a-proof-of-concept/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/post-operative-weight-loss-affects-3-year-survival-in-patients-with-gastric-adenocarcinoma-after-gastrectomy-and-hyperthermic-intraperitoneal-chemotherapy/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/recommandations-pour-la-pratique-clinique-nice-saint-paul-de-vence-2022-2023-prise-en-charge-du-cancer-de-lendometre-metastatique-et-ou-en-rechute/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/clinical-effectiveness-and-safety-of-olaparib-in-brca-mutated-her2-negative-metastatic-breast-cancer-in-a-real-world-setting-final-analysis-of-lucy/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/survival-and-modelled-cancer-antigen-125-elimination-rate-constant-k-score-in-ovarian-cancer-patients-in-first-line-before-polyadp-ribose-polymerase-inhibitor-era-a-gynaecologic-cancer-intergroup-m/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/management-of-trophoblastic-tumors-review-of-evidence-current-practice-and-future-directions/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/immunotherapy-for-gestational-trophoblastic-neoplasia-a-new-paradigm/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/neoadjuvant-chemotherapy-with-or-without-nintedanib-for-advanced-epithelial-ovarian-cancer-lessons-from-the-gineco-double-blind-randomized-phase-ii-chiva-trial/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/molecular-analyses-of-chorionic-type-intermediate-trophoblastic-lesions-atypical-placental-site-nodules-are-closer-to-placental-site-nodules-than-epithelioid-trophoblastic-tumors/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/mathematical-modeling-of-the-early-modeled-ca-125-longitudinal-kinetics-kelim-parp-as-a-pragmatic-indicator-of-rucaparib-efficacy-in-patients-with-recurrent-ovarian-carcinoma-in-ariel2-study-10/2025-03-25T17:41:34+01:00https://www.laboratoire-cicly.fr/publications/aso-author-reflections-which-is-the-optimal-preoperative-systemic-chemotherapy-regimen-for-patients-with-peritoneal-metastases-from-colorectal-cancer/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/benefit-from-fractionated-dose-dense-chemotherapy-in-patients-with-poor-prognostic-ovarian-cancer-icon-8-trial/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/morbidity-mortality-and-prognostic-factors-in-gestational-trophoblastic-neoplasia-with-liver-metastasis/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/sorafenib-in-molecularly-selected-cancer-patients-final-analysis-of-the-most-plus-sorafenib-cohort/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/parp-inhibitors-parpi-prolongation-after-local-therapy-for-oligo-metastatic-progression-in-relapsed-ovarian-cancer-patients/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/multiple-pregnancy-with-complete-hydatidiform-mole-and-coexisting-normal-fetus-in-a-retrospective-cohort-of-141-patients/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/clinical-results-of-the-evesor-trial-a-multiparameter-phase-i-trial-of-everolimus-and-sorafenib-combination-in-solid-tumors/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/avelumab-in-patients-with-gestational-trophoblastic-tumors-with-resistance-to-polychemotherapy-cohort-b-of-the-trophimmun-phase-2-trial-2/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/effect-of-capmatinib-on-the-pharmacokinetics-of-substrates-of-cyp3a-midazolam-and-cyp1a2-caffeine-in-patients-with-met-dysregulated-solid-tumours-2/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/a-pk-pd-model-linking-biomarker-dynamics-to-progression-free-survival-in-patients-treated-with-everolimus-and-sorafenib-combination-therapy-evesor-phase-i-trial/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/comparison-of-neoadjuvant-systemic-chemotherapy-protocols-for-the-curative-intent-management-of-peritoneal-metastases-from-colorectal-cancer-regarding-morphological-response-pathological-response-a/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/cheops-trial-a-gineco-group-randomized-phase-ii-assessing-addition-of-a-non-steroidal-aromatase-inhibitor-to-oral-vinorelbine-in-pre-treated-metastatic-breast-cancer-patients/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/ca-125-early-dynamics-to-predict-overall-survival-in-women-with-newly-diagnosed-advanced-ovarian-cancer-based-on-meta-analysis-data/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/antibody-drug-conjugates-adc-and-bispecific-antibodies-in-oncology-report-of-the-2022-saint-louis-day/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/anti-coagulant-treatment-of-cancer-associated-thrombosis-in-frail-patients-impact-of-frailties-on-the-management-of-drug-drug-interactions/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/enhancing-collaboration-between-geriatricians-oncologists-and-pharmacists-to-optimize-medication-therapy-in-older-adults-with-cancer-a-position-paper-from-sofog-sfpo/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/impact-of-pharmaceutical-care-interventions-on-multidisciplinary-care-of-older-patients-with-cancer-a-systematic-review/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/comparing-different-robots-available-in-the-european-market-for-the-preparation-of-injectable-chemotherapy-and-recommendations-to-users-3/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/clinical-and-economic-impact-of-clinical-oncology-pharmacy-in-cancer-patients-receiving-injectable-anticancer-treatments-a-systematic-review/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/access-and-safety-of-dexamethasone-in-multiple-myeloma-patients/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/clinical-impact-and-cost-saving-analysis-of-a-comprehensive-pharmaceutical-care-intervention-in-older-patients-with-cancer/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/sars-cov-2-pandemic-involvement-of-the-hospital-pharmacist-in-securing-patient-care/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/a-single-centre-experience-of-29-total-ankle-replacement-in-haemophiliac-patients-therapeutic-management-factor-consumption-and-cost/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/monitoring-multidimensional-aspects-of-quality-of-life-after-cancer-immunotherapy-protocol-for-the-international-multicentre-observational-qualitop-cohort-study/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/comparative-analysis-of-car-t-cell-therapy-access-for-dlbcl-patients-associated-challenges-and-solutions-in-the-four-largest-eu-countries/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/medication-assessment-in-older-adults-with-cancer-current-practices-in-clinical-pharmacy/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/deep-continuous-patient-requested-sedation-until-death-a-multicentric-study/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/methadone-and-neuropathic-cancer-pain-subcomponents-a-prospective-cohort-pilot-study/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/legalised-active-assistance-in-dying-palliative-care-stakeholders-national-e-consultation/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/withholding-or-withdrawing-life-sustaining-treatments-in-the-covid-19-pandemic-adherence-to-legal-standards/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/validation-of-a-french-version-of-the-breakthrough-pain-assessment-tool-in-cancer-patients-factorial-structure-reliability-and-responsiveness/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/ovarian-cancer-in-the-older-patient-where-are-we-now-what-to-do-next/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/development-of-indirect-health-data-linkage-on-health-product-use-and-care-trajectories-in-france-systematic-review/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/progression-free-survival-and-safety-at-3-5years-of-follow-up-results-from-the-randomised-phase-3-prima-engot-ov26-gog-3012-trial-of-niraparib-maintenance-treatment-in-patients-with-newly-diagnosed-o/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/veronique-trillet-lenoir/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/recommandations-francophones-pour-la-pratique-clinique-concernant-la-prise-en-charge-des-cancers-du-sein-de-saint-paul-de-vence-2022-2023/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/nirvana-1-maintenance-therapy-with-niraparib-versus-niraparib-bevacizumab-in-patients-with-advanced-ovarian-cancer/2025-03-25T17:41:35+01:00https://www.laboratoire-cicly.fr/publications/her2-positive-metastatic-breast-cancer-available-treatments-and-current-developments/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/impact-of-age-on-polyadp-ribose-polymerase-inhibitor-parpi-induced-lymphopenia-a-scoping-review-of-the-literature-and-internal-analysis-of-a-retrospective-database/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/olaparib-first-line-maintenance-monotherapy-in-brca-mutated-epithelial-ovarian-cancer-descriptive-analysis-of-the-first-french-real-world-data-study/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/multicenter-external-validation-of-the-deep-pelvic-endometriosis-index-magnetic-resonance-imaging-score/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/temporal-trends-in-the-use-of-computed-tomographic-pulmonary-angiography-for-suspected-pulmonary-embolism-in-the-emergency-department-a-retrospective-analysis/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/influence-of-extraperitoneal-metastases-on-the-curative-intent-management-of-colorectal-peritoneal-metastases/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/comparison-between-ct-enterography-and-mr-enterography-for-the-diagnosis-of-right-sided-deep-infiltrating-endometriosis-of-the-bowel/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/mri-restaging-of-rectal-cancer-the-rac-response-anal-canal-crm-analysis-joint-consensus-guidelines-of-the-grercar-and-greccar-groups/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/association-of-chemotherapy-and-comorbidities-with-overall-survival-in-elderly-patients-with-early-breast-cancer-a-french-population-based-propensity-score-matched-analysis/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/a-multicenter-comparative-matched-pair-analysis-of-percutaneous-tumor-ablation-and-robotic-assisted-partial-nephrectomy-of-t1b-renal-cell-carcinoma-ablatt1b-study-uroccr-80/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/percutaneous-tumor-ablation-versus-image-guided-robotic-assisted-partial-nephrectomy-for-ct1b-renal-cell-carcinoma-a-comparative-matched-pair-analysis-uroccr-80/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/the-level-of-glucose-in-pancreatic-cyst-fluid-is-more-accurate-than-carcinoembryonic-antigen-to-identify-mucinous-tumors-a-french-multicenter-study/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/temporary-inferior-vena-cava-filters-factors-associated-with-non-removal-2/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/ct-guided-percutaneous-radiofrequency-cordotomy-for-intractable-cancer-pain-a-technical-case-report/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/mri-in-rectal-cancer-an-institutional-real-life-analysis-of-technical-parameters/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/cavernous-sinus-thrombosis-linked-to-covid-19-infection-a-case-report/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/primary-peritoneal-hepatoid-adenocarcinoma-patients-treated-by-complete-cytoreductive-surgery-crs-and-hyperthermic-intraperitoneal-chemotherapy-hipec/2025-03-25T17:41:36+01:00https://www.laboratoire-cicly.fr/publications/evaluation-of-preventive-tract-embolization-with-standardized-gelatin-sponge-slurry-on-chest-tube-placement-rate-after-ct-guided-lung-biopsy-a-propensity-score-analysis/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/interferon-alfa-2b-in-patients-with-low-grade-lymphomatoid-granulomatosis-and-chemotherapy-with-da-epoch-r-in-patients-with-high-grade-lymphomatoid-granulomatosis-an-open-label-single-centre-phase/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-to-treat-pseudomyxoma-peritonei-of-ovarian-origin-a-retrospective-french-renape-group-study/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/olaparib-plus-durvalumab-with-or-without-bevacizumab-as-treatment-in-parp-inhibitor-naive-platinum-sensitive-relapsed-ovarian-cancer-a-phase-ii-multi-cohort-study/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/confirmation-of-the-utility-of-the-ca-125-elimination-rate-kelim-as-an-indicator-of-the-chemosensitivity-in-advanced-stage-ovarian-cancer-in-a-real-life-setting/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/clinical-impact-of-ca-125-elimination-rate-constant-k-kelim-on-surgical-strategy-in-advanced-serous-ovarian-cancer-patients/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/intraperitoneal-nivolumab-after-debulking-surgery-and-hyperthermic-intraperitoneal-chemotherapy-in-advanced-ovarian-cancer-a-phase-i-study-with-expansion-cohort/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/retrospective-analysis-of-uterine-involvement-in-low-grade-serous-ovarian-carcinoma/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/germline-brca1-2-status-and-chemotherapy-response-score-in-high-grade-serous-ovarian-cancer/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/estimated-fetal-radiation-dose-from-18-f-fdg-pet-ct-during-the-second-and-third-trimesters-of-pregnancy/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/consensus-on-drivers-of-maintenance-treatment-choice-and-patterns-of-care-in-advanced-ovarian-cancer/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/kelim-score-predicts-outcome-in-patients-with-platinum-resistant-refractory-recurrent-ovarian-cancer/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/fc%ce%b3r3a-polymorphism-influences-natural-killer-cell-activation-and-response-to-anti-pd-l1-avelumab-in-gestational-trophoblastic-neoplasia/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/tumor-intrinsic-chemosensitivity-assessed-by-kelim-and-prognosis-by-brca-status-in-patients-with-advanced-ovarian-carcinomas/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/prognostic-value-of-the-modeled-prostate-specific-antigen-kelim-confirmation-in-metastatic-castration-resistant-prostate-cancer-treated-with-taxanes-in-firstana/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/early-follow-up-of-outpatients-with-oral-anticancer-therapy-in-the-oncoral-multidisciplinary-community-hospital-program/2025-03-25T17:41:37+01:00https://www.laboratoire-cicly.fr/publications/prognostic-value-of-circulating-tumor-dna-at-diagnosis-and-its-early-decrease-after-one-cycle-of-neoadjuvant-chemotherapy-for-patients-with-advanced-epithelial-ovarian-cancer-an-ancillary-analysis-of/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/patterns-of-genomic-instability-in-2000-patients-with-ovarian-cancer-across-six-clinical-trials-evaluating-olaparib/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/health-related-quality-of-life-in-patients-with-hematologic-malignancies-treated-with-chimeric-antigen-receptor-t-cell-therapy-review-and-current-progress/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/attributes-for-a-discrete-choice-experiment-on-preferences-of-patients-for-oncology-pharmacy-consultations/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/impact-of-early-access-reform-on-oncology-innovation-in-france-approvals-patients-and-costs/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/cost-effectiveness-of-the-oncoral-multidisciplinary-programme-for-the-management-of-outpatients-taking-oral-anticancer-agents-at-risk-of-drug-related-event-protocol-for-a-pragmatic-randomised-control/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/eliminating-the-need-for-preoperative-intravenous-hyperhydration-sodium-thiosulfate-as-nephrotoxicity-prevention-in-hipec-treated-patients-a-retrospective-analysis/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/effectiveness-and-safety-of-an-innovative-silicone-extender-in-suture-reinforcement-or-dermatotraction-a-retrospective-study/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/real-life-evaluation-of-the-care-pathway-of-patients-eligible-for-axicabtagene-ciloleucel-treatment-analysis-of-a-multicenter-retrospective-cohort-impa-ct-study/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/validation-of-an-alternative-two-strip-method-for-the-quality-control-of-99mtctc-etifenin-techida/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/feasibility-of-a-screening-and-prevention-procedure-for-risks-associated-with-dysphagia-in-older-patients-in-geriatric-units-the-dysphaging-pilot-study-protocol/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/real-world-experience-with-cdk4-6-inhibition-in-the-old-and-oldest-old-with-a-diagnosis-of-breast-cancer/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/what-contributes-to-promote-sexual-health-in-cancer-palliative-care-a-realist-review/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/low-dose-methadone-added-to-another-opioid-for-cancer-pain-a-multicentre-prospective-study/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/legalisation-of-euthanasia-and-assisted-suicide-advanced-cancer-patient-opinions-cross-sectional-multicentre-study/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/pharmacy-education-and-clinical-pharmacy-training-in-france/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/patterns-of-initial-ovarian-cancer-recurrence-on-niraparib-maintenance-monotherapy-in-patients-with-no-baseline-evidence-of-disease-after-first-line-chemotherapy-an-ad-hoc-subgroup-analysis-of-prima/2025-03-25T17:41:38+01:00https://www.laboratoire-cicly.fr/publications/author-correction-bevacizumab-olaparib-and-durvalumab-in-patients-with-relapsed-ovarian-cancer-a-phase-ii-clinical-trial-from-the-gineco-group/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/progression-free-survival-and-safety-at-3-5-years-of-follow-up-results-from-the-randomized-phase-3-prima-engot-ov26-gog-3012-trial-of-niraparib-maintenance-treatment-in-patients-with-newly-diagn/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/bevacizumab-olaparib-and-durvalumab-in-patients-with-relapsed-ovarian-cancer-a-phase-ii-clinical-trial-from-the-gineco-group/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/single-agent-metronomic-versus-weekly-oral-vinorelbine-as-first-line-chemotherapy-in-patients-with-hr-positive-her2-negative-advanced-breast-cancer-the-randomized-tempo-breast-study/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/identification-of-patients-with-early-hr-her2-breast-cancer-at-high-risk-of-recurrence/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/hyperthermic-intraperitoneal-chemotherapy-in-colorectal-cancer/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/endometriosis-mr-mimickers-t2-hypointense-lesions/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/reasons-why-it-is-time-to-change-imaging-guidelines-on-endometriosis/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/endometriosis-mr-mimickers-t1-hyperintense-lesions/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/clues-to-revising-the-conventional-diagnostic-algorithm-for-endometriosis/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/diagnostic-mri-for-deep-pelvic-endometriosis-towards-a-standardized-protocol/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/correction-endometriosis-mr-mimickers-t2-hypointense-lesions/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-to-treat-pseudomyxoma-peritonei-of-ovarian-origin-a-retrospective-french-renape-group-study-2/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/metastatic-colorectal-cancer-treated-with-combined-liver-resection-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-hipec-predictive-factors-for-early-recurrence/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/imaging-in-pleural-mesothelioma-a-review-of-the-16th-international-conference-of-the-international-mesothelioma-interest-group/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/ct-venography-for-the-diagnosis-of-postpartum-venous-thromboembolism-a-prospective-multi-center-cohort-study/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/spectral-photon-counting-ct-hype-or-hope-for-colorectal-peritoneal-metastases-imaging/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/correction-diagnostic-mri-for-deep-pelvic-endometriosis-towards-a-standardized-protocol/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/aso-author-reflections-selected-multisite-metastatic-colorectal-cancer-patients-may-benefit-from-radical-multimodal-treatment/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/correlation-of-morphological-appearance-of-peritoneal-lesions-at-laparotomy-and-disease-at-pathological-assessment-in-patients-undergoing-cytoreductive-surgery-for-peritoneal-malignancy-results-of-ph/2025-03-25T17:41:39+01:00https://www.laboratoire-cicly.fr/publications/mri-classification-of-uterosacral-ligament-involvement-in-endometriosis-the-hotel-dieu-classification/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/impact-of-previous-abdominal-surgery-and-timing-of-peritoneal-metastases-on-accuracy-of-imaging-in-predicting-the-surgical-pci-a-report-from-the-precinct-study/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/imaging-of-peritoneal-metastases-of-ovarian-and-colorectal-cancer-joint-recommendations-of-esgar-esur-psogi-and-eanm/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/the-significance-of-the-morphological-appearance-of-peritoneal-lesions-on-imaging-in-patients-with-peritoneal-malignancies-a-report-from-phase-1-of-the-precinct-study/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/do-all-patients-with-cancer-thrombosis-have-the-same-risk-of-bleeding-and-recurrence-particularities-of-lung-cancer/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/patients-knowledge-about-renal-secondary-effects-of-anti-tumoral-drugs-and-renal-protection-measures/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/reverse-transcriptase-real-time-pcr-in-the-diagnostic-strategy-for-invasive-infections-caused-by-aspergillus-fumigatus/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/mycotic-aneurysm-due-to-magnusiomyces-capitatus-complicating-a-second-liver-transplant-in-a-colonized-patient/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/cryptococcus-neoformans-gattii-and-histoplasma-capsulatum-var-capsulatum-infections-on-tissue-sections-diagnostic-pitfalls-and-relevance-of-an-integrated-histomolecular-diagnosis/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/performance-of-a-region-of-interest-based-algorithm-in-diagnosing-international-society-of-urological-pathology-grade-group-%e2%89%a52-prostate-cancer-on-the-mri-first-database-cad-first-study/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/pancreatic-steatosis-is-a-strong-risk-factor-for-post-ercp-pancreatitis-an-emerging-concept/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/virtual-reality-for-interventional-radiology-patients-a-preliminary-study/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/clinical-outcomes-after-emergency-transarterial-renal-embolization-a-retrospective-study/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/pulmonary-recurrence-of-colorectal-mucinous-adenocarcinoma-and-sarcoidosis-on-18-f-fdg-pet-ct/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/visceral-artery-pseudoaneurysm-predictive-factors-for-clinical-success-after-transarterial-embolization/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/influence-of-covariates-on-18f-fdg-pet-ct-diagnostic-accuracy-for-liver-metastasis/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/cryoablation-for-treatment-of-peripheral-lung-metastases-from-colorectal-cancer-a-bicenter-retrospective-study/2025-03-25T17:41:40+01:00https://www.laboratoire-cicly.fr/publications/endovascular-retrieval-of-a-migrated-contraceptive-implant-into-the-pulmonary-artery-case-report-and-review-of-literature/2025-03-25T17:41:41+01:00https://www.laboratoire-cicly.fr/publications/percutaneous-fixation-with-internal-cemented-screws-for-iliac-lytic-bone-metastases-assessment-of-pain-and-quality-of-life-on-long-term-follow-up/2025-03-25T17:41:41+01:00https://www.laboratoire-cicly.fr/publications/lung-cancer-screening-by-low-dose-ct-scan-in-france-final-results-of-the-dep-kp80-study-after-three-rounds/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/large-b-cell-lymphomas-with-ccnd1-rearrangement-have-different-immunoglobulin-gene-breakpoints-and-genomic-profile-than-mantle-cell-lymphoma/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/capmatinib-efficacy-for-metex14-non-small-cell-lung-cancer-patients-results-of-the-ifct-2104-capmatu-study/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/correlation-of-morphological-appearance-of-peritoneal-lesions-at-laparotomy-and-disease-at-pathological-assessment-in-patients-undergoing-cytoreductive-surgery-for-peritoneal-malignancy-results-of-p-2/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/update-on-gene-fusions-and-the-emerging-clinicopathological-landscape-of-peritoneal-and-pleural-mesotheliomas-and-other-neoplasms/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/number-of-pressurized-intraperitoneal-aerosol-chemotherapy-pipac-treatments-is-associated-with-longer-survival-analysis-of-a-large-prospective-cohort-of-patients-with-unresectable-peritoneal-surfac/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/pipac-in-patients-with-peritoneal-metastases-from-gastrointestinal-tract-pipox01-an-open-label-non-comparative-phase-1-2-dose-escalation-and-expansion-trial/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/intraperitoneal-nivolumab-after-debulking-surgery-and-hyperthermic-intraperitoneal-chemotherapy-in-advanced-ovarian-cancer-a-phase-i-study-with-expansion-cohort-2/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/hyperthermic-intraperitoneal-chemotherapy-in-colorectal-cancer-2/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/peculiar-nuclear-atypia-associated-with-mdm2-gene-amplification-in-carcinoma-ex-pleomorphic-adenoma-harbouring-an-alteration-of-hmga2/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/characterization-of-a-molecularly-distinct-subset-of-oncocytic-pleomorphic-adenomas-myoepitheliomas-harboring-recurrent-zbtb47-as1plag1-gene-fusion/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/performance-of-a-region-of-interest-based-algorithm-in-diagnosing-international-society-of-urological-pathology-grade-group-%e2%89%a52-prostate-cancer-on-the-mri-first-database-cad-first-study-2/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/pulmonary-inflammation-decreases-with-ultra-protective-ventilation-in-experimental-ards-under-vv-ecmo-a-positron-emission-tomography-study/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-to-treat-pseudomyxoma-peritonei-of-ovarian-origin-a-retrospective-french-renape-group-study-3/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/sox10-internal-tandem-duplications-and-plag1-or-hmga2-fusions-segregate-eccrine-type-and-apocrine-type-cutaneous-mixed-tumors/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/aso-author-reflections-selected-multisite-metastatic-colorectal-cancer-patients-may-benefit-from-radical-multimodal-treatment-2/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/eliminating-the-need-for-preoperative-intravenous-hyperhydration-sodium-thiosulfate-as-nephrotoxicity-prevention-in-hipec-treated-patients-a-retrospective-analysis-2/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/aso-author-reflections-pseudomyxoma-peritonei-of-ovarian-origin-modern-approach-and-perspectives/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/metastatic-colorectal-cancer-treated-with-combined-liver-resection-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-hipec-predictive-factors-for-early-recurrence-2/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/role-of-gene-sequencing-in-classifying-struma-ovarii-braf-p-g469a-mutation-and-tert-promoter-alterations-favour-malignant-struma-ovarii/2025-03-25T19:35:05+01:00https://www.laboratoire-cicly.fr/publications/comparison-and-validation-of-rapid-molecular-testing-methods-for-theranostic-epidermal-growth-factor-receptor-alterations-in-lung-cancer-idylla-versus-digital-droplet-pcr/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/factors-associated-with-survival-in-anaplastic-thyroid-carcinoma-a-multicenter-study-from-the-endocan-tuthyref-network/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/association-of-pronounced-elevation-of-net-formation-and-nucleosome-biomarkers-with-mortality-in-patients-with-septic-shock/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/molecular-characterization-of-primary-mediastinal-large-b-cell-lymphomas/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/association-between-post-operative-hpg80-circulating-progastrin-detectable-level-and-worse-prognosis-in-glioblastoma/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/epidemiology-of-psychiatric-disorders-following-cytoreductive-surgeries-plus-hyperthermic-intraperitoneal-chemotherapy-a-prospective-cohort-analysis/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/circulating-h3k27-methylated-nucleosome-plasma-concentration-synergistic-information-with-circulating-tumor-dna-molecular-profiling/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/prognostic-value-of-programmed-death-ligand-1-and-programmed-death-1-expression-in-patients-with-upper-tract-urothelial-carcinoma/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/2022-psogi-consensus-on-hipec-regimens-for-peritoneal-malignancies-diffuse-malignant-peritoneal-mesothelioma/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/the-lncrna-rmst-is-drastically-downregulated-in-anaplastic-thyroid-carcinomas-where-exerts-a-tumor-suppressor-activity-impairing-epithelial-mesenchymal-transition-and-stemness/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/deciphering-the-spectrum-of-cutaneous-lymphomas-expressing-tfh-markers/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/post-operative-weight-loss-affects-3-year-survival-in-patients-with-gastric-adenocarcinoma-after-gastrectomy-and-hyperthermic-intraperitoneal-chemotherapy-2/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/survival-outcomes-prognostic-factors-and-effect-of-adjuvant-radiotherapy-and-prophylactic-neck-dissection-in-salivary-acinic-cell-carcinoma-a-prospective-multicenter-refcor-study-of-187-patients/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/external-multicentre-validation-of-pseudomyxoma-peritonei-psogi-ki67-classification/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/aso-author-reflections-colorectal-cancer-patients-with-peritoneal-metastases-and-other-metastatic-sites-can-benefit-from-radical-multifocal-treatment-after-comprehensive-evaluation-for-accurate-selec/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/paired-comparison-of-routine-molecular-screening-of-patient-samples-with-advanced-non-small-cell-lung-cancer-in-circulating-cell-free-dna-using-three-targeted-assays/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/influence-of-extraperitoneal-metastases-on-the-curative-intent-management-of-colorectal-peritoneal-metastases-2/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/comparison-of-neoadjuvant-systemic-chemotherapy-protocols-for-the-curative-intent-management-of-peritoneal-metastases-from-colorectal-cancer-regarding-morphological-response-pathological-response-a-2/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/bone-granulomatous-infiltrate-associated-with-mogamulizumab-in-a-patient-with-mycosis-fungoides/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/prone-position-decreases-acute-lung-inflammation-measured-by-11cr-pk11195-positron-emission-tomography-in-experimental-acute-respiratory-distress-syndrome/2025-03-25T19:35:06+01:00https://www.laboratoire-cicly.fr/publications/perioperative-chemotherapy-in-colorectal-cancer-with-peritoneal-metastases-a-global-propensity-score-matched-study/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/monomorphic-epitheliotropic-intestinal-t-cell-lymphoma-comprises-morphologic-and-genomic-heterogeneity-impacting-outcome/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/advances-in-the-management-of-peritoneal-malignancies-2/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/colorectal-liver-micrometastases-association-with-ras-tp53-co-mutation-and-prognosis-after-surgery/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/nivolumab-nivolumab-ipilimumab-and-vegfr-tyrosine-kinase-inhibitors-as-first-line-treatment-for-metastatic-clear-cell-renal-cell-carcinoma-bionikk-a-biomarker-driven-open-label-non-comparative/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/non-invasive-quantification-of-acute-macrophagic-lung-inflammation-with-11cr-pk11195-using-a-three-tissue-compartment-kinetic-model-in-experimental-acute-respiratory-distress-syndrome/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/assessing-criteria-for-a-safe-early-discharge-after-laparoscopic-colorectal-surgery/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/non-resectable-malignant-peritoneal-mesothelioma-treated-with-pressurized-intraperitoneal-aerosol-chemotherapy-pipac-plus-systemic-chemotherapy-could-lead-to-secondary-complete-cytoreductive-surgery-2/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/aso-author-reflections-bi-directional-chemotherapy-using-pipac-could-downstage-nonresectable-malignant-peritoneal-mesothelioma-patients-to-a-complete-resection-2/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/plasticity-of-mature-b-cells-between-follicular-and-classic-hodgkin-lymphomas-a-series-of-22-cases-expanding-the-spectrum-of-transdifferentiation/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/the-increasing-prognostic-and-predictive-roles-of-the-tumor-primary-chemosensitivity-assessed-by-ca-125-elimination-rate-constant-k-kelim-in-ovarian-cancer-a-narrative-review-2/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/her2-expression-in-circulating-tumor-cells-is-associated-with-poor-outcomes-in-patients-with-metastatic-castration-resistant-prostate-cancer-2/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/azole-resistance-in-aspergillus-fumigatus-isolates-from-respiratory-specimens-in-lyon-university-hospitals-france-prevalence-and-mechanisms-involved/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/tobacco-induced-sleep-disturbances-a-systematic-review-and-meta-analysis/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/prognosis-of-poorly-cohesive-gastric-cancer-after-complete-cytoreductive-surgery-with-or-without-hyperthermic-intraperitoneal-chemotherapy-cyto-chip-study/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/clinicopathological-features-and-survival-in-ebv-positive-diffuse-large-b-cell-lymphoma-not-otherwise-specified/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/troponin-measurement-for-risk-stratification-after-cytoreductive-surgery/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/longitudinal-assessment-of-pd-l1-expression-and-gene-expression-profiles-in-patients-with-head-and-neck-cancer-reveals-temporal-heterogeneity/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/orai3-mediates-cisplatin-resistance-in-non-small-cell-lung-cancer-cells-by-enriching-cancer-stem-cell-population-through-pi3k-akt-pathway/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/functional-outcomes-of-soft-palate-free-flap-reconstruction-following-oropharyngeal-cancer-surgery/2025-03-25T19:35:07+01:00https://www.laboratoire-cicly.fr/publications/issues-and-limitations-of-available-biomarkers-for-fluoropyrimidine-based-chemotherapy-toxicity-a-narrative-review-of-the-literature/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/influence-of-postoperative-radiotherapy-target-volumes-in-unilateral-head-and-neck-carcinoma-of-unknown-primary-a-multicentric-study-using-propensity-score/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/real-life-targeted-next-generation-sequencing-for-lymphoma-diagnosis-over-1-year-from-the-french-lymphoma-network/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/intergroupe-francophone-de-cancerologie-thoracique-societe-de-pneumologie-de-langue-francaise-and-societe-dimagerie-thoracique-statement-paper-on-lung-cancer-screening/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/oropharyngeal-squamous-cell-carcinoma-p16-p53-immunohistochemistry-as-a-strong-predictor-of-hpv-tumour-status/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/prevalence-and-distribution-of-cervical-lymph-node-metastases-in-hpv-positive-and-hpv-negative-oropharyngeal-squamous-cell-carcinoma/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/implications-of-pathologic-findings-in-cytoreductive-surgery-specimens-on-treatment-of-colorectal-peritoneal-metastases-results-of-a-prospective-multicentric-study/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/site-of-recurrence-and-survival-after-surgery-for-colorectal-peritoneal-metastasis/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/prognostic-impact-of-pt3-subclassification-in-a-multicentre-cohort-of-patients-with-urothelial-carcinoma-of-the-renal-pelvicalyceal-system-undergoing-radical-nephroureterectomy-a-propensity-score-wei/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/men1-disruption-in-nkx3-1-deficient-mice-results-in-arlow-cd44-microinvasive-carcinoma-development-with-the-dysregulated-ar-pathway/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/aso-author-reflections-potential-therapeutic-implications-and-prediction-of-pathological-complete-response-to-systemic-chemotherapy-in-colorectal-peritoneal-metastases/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/clinical-and-radiologic-predictors-of-a-pathologic-complete-response-to-neoadjuvant-chemotherapy-nact-in-patients-undergoing-cytoreductive-surgery-for-colorectal-peritoneal-metastases-results-of-a-2/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/lung-screening-benefits-and-challenges-a-review-of-the-data-and-outline-for-implementation/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/a-diagnostic-approach-to-the-identification-of-burkitt-like-lymphoma-with-11q-aberration-in-aggressive-b-cell-lymphomas/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/distribution-of-residual-disease-in-the-peritoneum-following-neoadjuvant-chemotherapy-in-advanced-epithelial-ovarian-cancer-and-its-potential-therapeutic-implications/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/peritoneal-metastases-management-towards-the-era-of-prospective-randomized-trials/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/pressurized-intraperitoneal-aerosol-chemotherapy-pipac-for-unresectable-peritoneal-metastasis-from-gastric-cancer/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/peritoneal-mesothelioma-psogi-euracan-clinical-practice-guidelines-for-diagnosis-treatment-and-follow-up/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/appendiceal-tumours-and-pseudomyxoma-peritonei-literature-review-with-psogi-euracan-clinical-practice-guidelines-for-diagnosis-and-treatment/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/improved-androgen-receptor-splice-variant-7-detection-using-a-highly-sensitive-assay-to-predict-resistance-to-abiraterone-or-enzalutamide-in-metastatic-prostate-cancer-patients-2/2025-03-25T19:35:08+01:00https://www.laboratoire-cicly.fr/publications/unresectable-peritoneal-metastasis-treated-by-pressurized-intraperitoneal-aerosol-chemotherapy-pipac-leading-to-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/the-delphi-and-grade-methodology-used-in-the-psogi-2018-consensus-statement-on-pseudomyxoma-peritonei-and-peritoneal-mesothelioma/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/pressurized-intraperitoneal-aerosol-chemotherapy-pipac-in-association-with-systemic-chemotherapy-and-bevacizumab-evaluation-of-safety-and-feasibility-a-single-center-comparative-study/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/a-phase-i-dose-escalation-study-of-oxaliplatin-delivered-via-a-laparoscopic-approach-using-pressurised-intraperitoneal-aerosol-chemotherapy-for-advanced-peritoneal-metastases-of-gastrointestinal-tract/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/prospective-correlation-of-the-radiological-surgical-and-pathological-findings-in-patients-undergoing-cytoreductive-surgery-for-colorectal-peritoneal-metastases-implications-for-the-preoperative-est/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/identification-of-intraductal-carcinoma-of-the-prostate-on-tissue-specimens-using-raman-micro-spectroscopy-a-diagnostic-accuracy-case-control-study-with-multicohort-validation/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/spectral-photon-counting-ct-imaging-of-colorectal-peritoneal-metastases-initial-experience-in-rats-2/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/risk-of-omental-metastases-in-patients-undergoing-cytoreductive-surgery-for-colorectal-peritoneal-metastases/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/18f-fdg-pet-ct-of-a-rare-case-of-an-adenomatoid-tumor-of-the-adrenal-gland/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/association-between-immune-related-adverse-events-and-long-term-survival-outcomes-in-patients-treated-with-immune-checkpoint-inhibitors-2/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/multicystic-and-diffuse-malignant-peritoneal-mesothelioma-in-children/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/prognostic-impact-of-combined-progression-index-based-on-peritoneal-grading-regression-score-and-peritoneal-cytology-in-peritoneal-metastasis/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/esr-ers-statement-paper-on-lung-cancer-screening/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/the-pathologic-peritoneal-cancer-index-pci-strongly-differs-from-the-surgical-pci-in-peritoneal-metastases-arising-from-various-primary-tumors/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/composite-and-sequential-lymphoma-between-classical-hodgkin-lymphoma-and-primary-mediastinal-lymphoma-diffuse-large-b-cell-lymphoma-a-clinico-pathological-series-of-25-cases/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/the-long-non-coding-rna-prader-willi-angelman-region-rna5-par5-is-downregulated-in-anaplastic-thyroid-carcinomas-where-it-acts-as-a-tumor-suppressor-by-reducing-ezh2-activity/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/the-oncogenic-and-druggable-hpg80-progastrin-is-overexpressed-in-multiple-cancers-and-detected-in-the-blood-of-patients-2/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/cisplatin-unleashes-toll-like-receptor-3-mediated-apoptosis-through-the-downregulation-of-c-flip-in-malignant-mesothelioma/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/target-region-resection-in-patients-undergoing-cytoreductive-surgery-for-peritoneal-metastases-is-it-necessary-in-absence-of-visible-disease/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/poorly-differentiated-neuroendocrine-carcinoma-of-the-head-and-neck-human-papillomavirus-tumour-status-p16-status-and-impact-on-overall-survival/2025-03-25T19:35:09+01:00https://www.laboratoire-cicly.fr/publications/pressurized-intraperitoneal-aerosol-chemotherapy-pipac-might-increase-the-risk-of-anastomotic-leakage-compared-to-hipec-an-experimental-study/2025-03-25T19:35:10+01:00https://www.laboratoire-cicly.fr/publications/peritonectomy-procedures-for-peritoneal-surface-malignancies-psogi-esgo-isspp-lyon-consensus/2025-09-11T15:50:35+02:00https://www.laboratoire-cicly.fr/publications/peritoneal-surface-malignancy-performing-complete-cytoreduction-in-occult-peritoneal-spaces-is-challenging/2025-09-11T15:57:19+02:00https://www.laboratoire-cicly.fr/publications/peritonectomy-to-enhance-adequate-cytoreductive-surgery-in-peritoneal-surface-malignancy-review-of-nomenclature-and-boundaries/2025-09-12T09:35:23+02:00https://www.laboratoire-cicly.fr/publications/hyperthermic-intraperitoneal-chemotherapy-for-recurrent-ovarian-cancer-chipor-a-randomised-open-label-phase-3-trial/2025-09-12T09:37:49+02:00https://www.laboratoire-cicly.fr/publications/the-2022-psogi-international-consensus-on-hipec-regimens-for-peritoneal-malignancies-hipec-technologies/2025-09-12T09:40:30+02:00https://www.laboratoire-cicly.fr/publications/advances-in-the-management-of-peritoneal-malignancies-3/2025-09-12T09:49:24+02:00https://www.laboratoire-cicly.fr/publications/cytoreductive-surgery-plus-hyperthermic-intraperitoneal-chemotherapy-versus-cytoreductive-surgery-alone-for-colorectal-peritoneal-metastases-prodige-7-a-multicentre-randomised-open-label-phase-3/2025-09-12T09:51:33+02:00https://www.laboratoire-cicly.fr/publications/pressurised-intraperitoneal-aerosol-chemotherapy-rationale-evidence-and-potential-indications/2025-09-12T09:53:08+02:00https://www.laboratoire-cicly.fr/publications/cytoreductive-surgery-with-or-without-hyperthermic-intraperitoneal-chemotherapy-for-gastric-cancer-with-peritoneal-metastases-cyto-chip-study-a-propensity-score-analysis/2025-09-12T09:55:15+02:00https://www.laboratoire-cicly.fr/publications/number-of-pressurized-intraperitoneal-aerosol-chemotherapy-pipac-treatments-is-associated-with-longer-survival-analysis-of-a-large-prospective-cohort-of-patients-with-unresectable-peritoneal-surfac-2/2025-09-12T09:56:55+02:00